Fecal Incontinence Clinical Trial
Official title:
The Effect of Physiotherapy for the Treatment of Fecal Incontinence - a Randomized, Controlled Trial.
Fecal incontinence is the complaint of involuntary loss of feces. Fecal incontinence affects
2-12% of the adult population. It is a hidden problem - less than one third of the affected
persons discuss the problem with their doctor. The condition has a negative effect on quality
of life. It is associated with shame and limitation in social life, leisure, occupational and
sexual activities.
Pelvic floor muscle exercises with or without the use of biofeedback has been recommended and
used for the treatment of fecal incontinence over the last decades. Several uncontrolled
trials and some controlled trials have shown a positive effect of this training, but most of
the trials are small and/or have methodological problems. Therefore there is to day still a
lack of sufficient evidence for the effect of pelvic floor muscle exercise as a treatment of
fecal incontinence.
The aim of this study is to compare the effect of an individual physiotherapeutic supervised
pelvic floor muscle training program with a control physiotherapeutic treatment (massage of
the neck and back). Both treatments will be given parallel with standard information and
guidance given by a nurse specialized in anal incontinence issues.
Study hypothesis: Pelvic floor muscle exercises given parallel with standard advice and
guidance by a specialized nurse, provides better effect to reducing fecal incontinence than
control treatment and standard advice alone.
Prospective, investigator blinded, randomized controlled trial with two parallel arms. 100
participants will be randomized to one of two groups. Ratio 1:1. Baseline data consists of a
physical examination, anal ultrasound and a thorough medical history including age, duration
of complaints, fecal incontinence specific symptoms and known risk factors for fecal
incontinence.
Group 1 will receive standard information and guidance and care by a specialized nurse. The
treatment consists of advice about diet and fiber supplements and information about
optimizing bowel emptying and use of antidiarrheal medication if appropriate. In addition the
participants will receive six individual treatments of 30 minutes by a physiotherapist. This
treatments will consist of massage of the back and neck. The participants will get no
instructions on pelvic floor muscle exercises.
Group 2 will receive the same information and guidance by a specialist nurse as group 1. In
addition they will receive six individual treatments of 45 minutes by a physiotherapist
specialized in incontinence problems and pelvic floor disorders. The participants will get
instructions in the anatomy and function of the pelvic floor muscles and instructions on how
to do a correct pelvic floor muscle contraction. The pelvic floor muscle exercises will be
taught both by verbal instructions and by vaginal and anal palpation. For each session by the
physiotherapist, the participants will get a physiotherapeutic examination of the pelvic
floor muscles by a vaginal and rectal examination. The pelvic floor muscle and the external
anal sphincter strength will be measured according to the Modified Oxford Score (ranging
0-5). Endurance of sub-maximal contractions will be determined. The function of pelvic floor
muscle will also be measured with intra-anal EMG biofeedback. Biofeedback will be used to
give the participant visual and auditory feedback on a correct pelvic floor muscle
contraction to enhance the participants awareness, strength and endurance of a correct pelvic
floor muscle contraction. Biofeedback will also be used in sitting and standing position to
assess the pelvic floor muscle function in those positions. According to the findings of the
physiotherapeutic examinations there will be prepared an individual adapted pelvic floor
muscle training program. The program consists of 3 sets of 10 contractions sustained up till
10 seconds and 2 sets of 3 contractions sustained up till 30 seconds. 1 minute rest between
each set. The participants will also be instructed in how to contract the pelvic floor in
response to anal urgency and in situations with increased intra abdominal pressure. The
participants will be encouraged to perform the training program on a daily basis and will be
instructed in filling out a training dairy. The diary will be used as a motivational tool and
to quantify the amount of training. The individual training program will be adjusted, based
on the findings from the examinations, and participants will be instructed to perform the
exercises in different positions and during movements e.g. transfers, lifting, walking,
coughing.
The treatments in both groups will be distributed over 16 weeks, with treatment in week
0,2,5,8,12 and 16.
Note 15. februar 2016:
Due to logistical reasons, we failed to perform the 12 months follow-up in the first 15
patients, which is why we decided to change the follow-up from 12 months to 36 months. This
will enable us to perform a long-term outcome assessment for all included patients. This
change does not affect the pre-specified primary endpoint.
In order to achieve as high respond rate as possible we decided to restrict the follow-up
measurement to the questionnaires: Patient Global Impression of Improvement Scale (PGI-I
scale), Fecal Incontinence Severity Index (FISI), St. Marks Incontinence Score (Vaizey) and
Fecal Incontinence Quality of Life Scale (FIQL). Questions about further treatment for fecal
incontinence since completion of the study and the amount of current pelvic floor muscle
exercise will be added.
We thus decided to omit anal manometry, rectal capacity measurement and diaries from the 36
months follow-up measurements.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03825575 -
Sacral Neuromodulation as Treatment for Fecal Incontinence
|
N/A | |
Completed |
NCT00605826 -
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
|
N/A | |
Withdrawn |
NCT02208258 -
Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.
|
N/A | |
Completed |
NCT01957969 -
French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT01939821 -
A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Recruiting |
NCT00530933 -
Tibial Nerve Stimulation for Faecal Incontinence
|
N/A | |
Withdrawn |
NCT00522691 -
Efficacy of Sacral Nerve Stimulation Before Definitive Implantation
|
N/A | |
Completed |
NCT00565136 -
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00677508 -
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
|
||
Completed |
NCT05032534 -
Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence
|
N/A | |
Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
Completed |
NCT03746834 -
NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
|
Phase 4 | |
Completed |
NCT00124904 -
Biofeedback for Fecal Incontinence
|
N/A | |
Completed |
NCT03028636 -
LIBERATE - PRO: Eclipseâ„¢ System Registry
|
||
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 | |
Completed |
NCT05621629 -
Management of FI After Surgery of ARM
|
||
Withdrawn |
NCT04138602 -
BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT03252951 -
Physical Therapy for Anal Incontinence
|
N/A | |
Completed |
NCT04478799 -
Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience
|
N/A |